VivoSim Labs, Inc. (VIVS): Total Assets
$7.39M
As of 2026-03-31
$3.85M
As of 2026-06-30
-28.6%
3-year compound annual growth
-28.6%
5-year compound annual growth
-19.9%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $7.39M | -49.6% | 2026-07-14, Balance as of period end |
| 2025-03-31 | $14.65M | +130.7% | 2026-07-14, Balance as of period end |
| 2024-03-31 | $6.35M | -68.7% | 2025-06-05, Balance as of period end |
| 2023-03-31 | $20.31M | -39.0% | 2024-05-31, Balance as of period end |
| 2022-03-31 | $33.30M | -16.6% | 2023-07-14, Balance as of period end |
| 2021-03-31 | $39.92M | +40.4% | 2022-06-10, Balance as of period end |
| 2020-03-31 | $28.44M | -30.0% | 2021-06-15, Balance as of period end |
| 2019-03-31 | $40.62M | -18.5% | 2020-05-28, Balance as of period end |
| 2018-03-31 | $49.83M | -28.0% | 2019-06-03, Balance as of period end |
| 2017-03-31 | $69.18M | +2.4% | 2018-05-31, Balance as of period end |
| 2016-03-31 | $67.58M | +26.3% | 2017-06-07, Balance as of period end |
| 2015-03-31 | $53.49M | +6.6% | 2016-06-09, Balance as of period end |
| 2014-03-31 | $50.19M | +188.8% | 2015-06-09, Balance as of period end |
| 2013-03-31 | $17.38M | n/a | 2014-06-10, Balance as of period end |
| 2012-12-31 | $16.75M | n/m | 2014-06-10, Balance as of period end |
| 2011-12-31 | $1.41M | n/a | 2013-03-15, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| VivoSim Labs, Inc. (VIVS) | 2026-03-31 | $7.39M | -49.6% |
| Zivo Bioscience, Inc. (ZIVO) | 2024-12-31 | $1.64M | +195.7% |
| aTYR PHARMA INC (ATYR) | 2025-12-31 | $93.00M | -4.0% |
| AIM ImmunoTech Inc. (AIM) | 2025-12-31 | $5.78M | -32.8% |
| Inmune Bio, Inc. (INMB) | 2025-12-31 | $32.35M | -18.2% |
| Entera Bio Ltd. (ENTX) | 2025-12-31 | $15.99M | +70.3% |
| Cardiff Oncology, Inc. (CRDF) | 2025-12-31 | $61.88M | -36.3% |
| Senti Biosciences Holdings, Inc. (SNTI) | 2025-12-31 | $51.22M | -47.6% |
| ImageneBio, Inc. (IMA) | 2025-12-31 | $152.98M | +860.8% |
Compare VIVS, ZIVO, ATYR, AIM side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗